CARL vs. NVCR, CNMD, KMTS, PLSE, BLFS, ESTA, SSII, MDXG, INMD, and IRMD
Should you be buying Carlsmed stock or one of its competitors? The main competitors of Carlsmed include NovoCure (NVCR), CONMED (CNMD), Kestra Medical Technologies (KMTS), Pulse Biosciences (PLSE), BioLife Solutions (BLFS), Establishment Labs (ESTA), SS Innovations International (SSII), MiMedx Group (MDXG), InMode (INMD), and iRadimed (IRMD). These companies are all part of the "medical equipment" industry.
Carlsmed vs. Its Competitors
Carlsmed (NASDAQ:CARL) and NovoCure (NASDAQ:NVCR) are both small-cap medical equipment companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings, analyst recommendations and media sentiment.
Carlsmed has higher earnings, but lower revenue than NovoCure.
NovoCure has a consensus target price of $27.50, indicating a potential upside of 95.73%. Given NovoCure's stronger consensus rating and higher probable upside, analysts clearly believe NovoCure is more favorable than Carlsmed.
84.6% of NovoCure shares are owned by institutional investors. 5.5% of NovoCure shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
In the previous week, NovoCure had 6 more articles in the media than Carlsmed. MarketBeat recorded 7 mentions for NovoCure and 1 mentions for Carlsmed. Carlsmed's average media sentiment score of 0.00 beat NovoCure's score of -0.19 indicating that Carlsmed is being referred to more favorably in the media.
Carlsmed has a net margin of 0.00% compared to NovoCure's net margin of -27.13%. Carlsmed's return on equity of 0.00% beat NovoCure's return on equity.
Summary
NovoCure beats Carlsmed on 7 of the 12 factors compared between the two stocks.
Get Carlsmed News Delivered to You Automatically
Sign up to receive the latest news and ratings for CARL and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding CARL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Carlsmed Competitors List
Related Companies and Tools
This page (NASDAQ:CARL) was last updated on 10/3/2025 by MarketBeat.com Staff
Free CARL Stock Alerts